Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone propionate in smoking-related COPD
ACTRN12607000249459Phase 4Completed
- Sponsor
- GSK
- Start
- Jan 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 4, randomised trial in chronic obstructive pulmonary disease (COPD) comparing Fluticasone propionate with Placebo (2 arms). Primary endpoint: Change in cellular airway inflammation. Started Jan 2004; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ACTRN12607000249459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000249459.